Chitosan-N-acetyl cysteine conjugates: In vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties

Drug Delivery

Volumn 15, Issue 4, 2008, Pages 245-252

  Schmitz, Thierry ^a   Hombach, Juliane ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Chitosan N acetyl Cysteine; Cytotoxicity; FD 4; P gp; Rhodamine 123

Indexed keywords

ACETYLCYSTEINE; CHITOSAN; DRUG CARRIER; GLYCOPROTEIN P; LACTATE DEHYDROGENASE; RHODAMINE 123; TETRAZOLIUM BLUE;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; COLON CANCER; CONJUGATE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY TEST; DRUG ABSORPTION; EVALUATION; HUMAN; HUMAN CELL; INTESTINE; MOLECULAR WEIGHT; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ANIMALS; CACO-2 CELLS; CHITOSAN; DEXTRANS; DRUG CARRIERS; FLUORESCEINS; HUMANS; L-LACTATE DEHYDROGENASE; MOLECULAR WEIGHT; P-GLYCOPROTEIN; PERMEABILITY; RATS; RHODAMINE 123; TOXICITY TESTS;

EID: 43049096476     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802006708     Document Type: Article

References (25)

1. Bernkop-Schnürch, A., Kast, C. E., and Guggi, D. 2003. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J. Control. Release 93:95-103.
2. Bernkop-Schnürch, A., Hornof, M., and Guggi, D. 2004. Thiolated chitosans. Eur. J. Pharm. Biopharm. 57:9-17.
3. Clausen, A. E., Kast, C. E., and Bernkop-Schnürch, A. 2002. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 19:602-608.
4. D'Emanuele, A., Jevprasesphant, R., Penny, J., and Attwood, D. 2004. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability (vol 95 pg 447 2004). J. Control. Release 96:513-513.
5. Decker, T., and Lohmannmatthes, M. L. 1988. A Quick and simple method for the quantitation of lactate-dehydrogenase release in measurements of cellular cyto-toxicity and tumor necrosis factor (Tnf) activity. J. Immunol. Methods 115:61-69.
6. Demeule, M., Brossard, M., Turcotte, S., Regina, A., Jodoin, J., and Beliveau, R. 2004. Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression. Biochem. Biophys. Res. Commun. 324:937-945.
7. Föger, F., Schmitz, T., and Bernkop-Schnürch, A. 2006. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27:4250-4255.
8. Guggi, D., and Bernkop-Schnürch, A. 2005. Improved paracellular uptake by the combination of different types of permeation enhancers. Int. J. Pharm. 288:141-150.
9. Ho, G. T., Moodie, F. M., and Satsangi, J. 2003. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52:759-766.
10. Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., and Borchardt, R. T. 2002. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 91:1991-2002.
11. Imam, M. E., Hornof, M., Valenta, C., Reznicek, G., and Bernkop-Schnürch, A. 2003. Evidence for the interpenetration of mucoadhesive polymers into the mucus gel layer. S. T. P. Pharma Sci. 13:171-176.
12. Kabanov, A. V., Batrakova, E. V., and Alakhov, V. Y. 2002. Pluronic block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev. 54:759-779.
13. Legrand, C., Bour, J. M., Jacob, C., Capiaoumont, J., Martial, A., Marc, A., Wudtke, M., Kretzmer, G., Demangel, and C., Duval, D. 1992. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]. J. Biotechnol. 25:231-243.
14. Liu, R., and Sharom, F. J. 1996. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35:11865-11873.
15. Loo, T. W., and Clarke, D. M. 2000. Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites. J. Biol. Chem. 275:19435-19438.
16. Loo, T. W., and Clarke, D. M. 2000. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J. Natl. Cancer Inst. 92:898-902.
17. Loo, T. W., Bartlett, M. C., and Clarke, D. M. 2003. Substrate-induced conformational, changes in the transmembrane segments of human P-glycoprotein - Direct evidence for the substrate-induced fit mechanism for drug binding. J. Biol. Chem. 278:13603-13606.
18. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
19. Ohkubo, R., Tomita, M., Hotta, Y., Nagira, M., and Hayashi, M. 2003. Comparative study of flux of FITC-labeled Dextran 4000 on normal (iso)- and hyper-osmolarity in basal side in caco-2 cell monolayers. Drug Metab. Pharmacokinet. 18:404-408.
20. Regev, R., Assaraf, Y. G., and Eytan, G. D., 1999. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. Eur. J. Biochem. 259:18-24.
21. Schmitz, T., Grabovac, V., Palmberger, T. F., Hoffer, M. H., and Bernkop-Schnürch, A. 2008. Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate. Int. J. Pharm. 347:79-85.
22. Tomita, M., Hotta, Y., Ohkubo, R., and Awazu, S. 1999. Polarized transport was observed not in hydrophilic compounds but in dextran in Caco-2 cell monolayers. Biol. Pharm. Bull. 22:330-331.
23. Varma, M. V. S., Ashokraj, Y., Dey, C. S., and Panchagnula, R. 2003. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol. Res. 48:347-359.
24. Werle, M., and Hoffer, M. 2005. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J. Control. Release 111:41-46.
25. Zhou, X. H., and Po, A. L. W. 1991. Peptide and protein drugs.1. Therapeutic applications, absorption and parenteral administration. Int. J. Pharm. 75:97-115.